Assessing the efficacy and safety of stereotactic radiosurgery for cerebral cavernous malformations

Takeaway

  • Available evidence indicates no harm, but no significant benefit, with stereotactic radiosurgery (SRS) for cerebral cavernous malformations (CCM), but more data are needed.

Why this matters

  • Current treatment of CCM typically includes conservative treatment (CON), microsurgical excision (ME), or SRS.

  • The role of SRS in CCM management is unclear.

  • Current information on the relative benefit of SRS may inform clinicians’ decisions regarding its use.